|
1
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar
|
|
2
|
DeBerardinis RJ and Chandel NS:
Fundamentals of cancer metabolism. Sci Adv. 2:e16002002016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abrahamsen O, Balslev E and Høgdall E:
Targeting the supply lines of cancer-A possible strategy for
combating the disease? Anticancer Res. 41:2737–2744. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pavlova NN and Thompson CB: The emerging
hallmarks of cancer metabolism. Cell Metab. 23:27–47. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barua R, Templeton AJ, Seruga B, Ocana A,
Amir E and Ethier JL: Hyperglycaemia and survival in solid Tumours:
A systematic review and Meta-analysis. Clin Oncol (R Coll Radiol).
30:215–224. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simon JM, Thomas F, Czernichow S, Hanon O,
Lemogne C, Simon T, Pannier B and Danchin N: Hyperglycaemia is
associated with cancer-related but not non-cancer-related deaths:
Evidence from the IPC cohort. Diabetologia. 61:1089–1097. 2018.
View Article : Google Scholar
|
|
7
|
Murtola TJ, Sälli SM, Talala K, Taari K,
Tammela TLJ and Auvinen A: Blood glucose, glucose balance, and
disease-specific survival after prostate cancer diagnosis in the
Finnish randomized study of screening for prostate cancer. Prostate
Cancer Prostatic Dis. 22:453–460. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen S, Tao M, Zhao L and Zhang X: The
association between diabetes/hyperglycemia and the prognosis of
cervical cancer patients: A systematic review and meta-analysis.
Medicine (Baltimore). 96:e79812017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu D, Peng F, Lin X, Chen G, Liang B, Li
C, Zhang H, Liao X, Lin J, Zheng X and Niu W: The elevated
preoperative fasting blood glucose predicts a poor prognosis in
patients with esophageal squamous cell carcinoma: The Fujian
prospective investigation of cancer (FIESTA) study. Oncotarget.
7:65247–65256. 2016. View Article : Google Scholar
|
|
10
|
Contiero P, Berrino F, Tagliabue G,
Mastroianni A, Di Mauro MG, Fabiano S, Annulli M and Muti P:
Fasting blood glucose and long-term prognosis of non-metastatic
breast cancer: A cohort study. Breast Cancer Res Treat.
138:951–959. 2013. View Article : Google Scholar
|
|
11
|
Nik-Ahd F, Howard LE, Eisenberg AT,
Aronson WJ, Terris MK, Cooperberg MR, Amling CL, Kane CJ and
Freedland SJ: Poorly controlled diabetes increases the risk of
metastases and castration-resistant prostate cancer in men
undergoing radical prostatectomy: Results from the SEARCH database.
Cancer. 125:2861–2867. 2019.PubMed/NCBI
|
|
12
|
Berker Y, Vandergrift LA, Wagner I, Su L,
Kurth J, Schuler A, Dinges SS, Habbel P, Nowak J, Mark E, et al:
Magnetic resonance spectroscopy-based metabolomic biomarkers for
typing, staging, and survival estimation of early-stage human lung
cancer. Sci Rep. 9:103192019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ling HH, Pan YP, Fan CW, Tseng WK, Huang
JS, Wu TH, Chou WC, Wang CH, Yeh KY, Chang PH, et al: Clinical
significance of serum glutamine level in patients with colorectal
cancer. Nutrients. 11:8982019. View Article : Google Scholar
|
|
14
|
Ma H, Hasim A, Mamtimin B, Kong B, Zhang
HP and Sheyhidin I: Plasma free amino acid profiling of esophageal
cancer using high-performance liquid chromatography spectroscopy.
World J Gastroenterol. 20:8653–8659. 2014. View Article : Google Scholar
|
|
15
|
Zheng H, Dong B, Ning J, Shao X, Zhao L,
Jiang Q, Ji H, Cai A, Xue W and Gao H: NMR-based metabolomics
analysis identifies discriminatory metabolic disturbances in tissue
and biofluid samples for progressive prostate cancer. Clin Chim
Acta. 501:241–251. 2020. View Article : Google Scholar
|
|
16
|
Jobard E, Pontoizeau C, Blaise BJ,
Bachelot T, Elena-Herrmann B and Tredan O: A serum nuclear magnetic
resonance-based metabolomic signature of advanced metastatic human
breast cancer. Cancer Lett. 343:33–41. 2014. View Article : Google Scholar
|
|
17
|
Cantor JR and Sabatini DM: Cancer cell
metabolism: One hallmark, many faces. Cancer Discov. 2:881–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boroughs LK and Deberardinis RJ: Metabolic
pathways promoting cancer cell survival and growth. Nat Cell Biol.
17:351–359. 2015. View
Article : Google Scholar
|
|
19
|
Peake RWA, Law T, Hoover PN, Gaewsky L,
Shkreta A and Kellogg MD: Improved separation and analysis of
plasma amino acids by modification of the MassTrakTM AAA
Solution Ultraperformance® liquid chromatography method.
Clin Chim Acta. 423:75–82. 2013. View Article : Google Scholar
|
|
20
|
Bi X and Henry CJ: Plasma-free amino acid
profiles are predictors of cancer and diabetes development. Nutr
Diabetes. 7:e2492017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Teoh ST and Lunt SY: Metabolism in cancer
metastasis: Bioenergetics, biosynthesis, and beyond. Wiley
Interdiscip Rev Syst Biol Med. 102018.doi: 10.1002/wsbm.1406.
|
|
23
|
Mosharov E, Cranford MR and Banerjee R:
The quantitatively important relationship between homocysteine
metabolism and glutathione synthesis by the transsulfuration
pathway and its regulation by redox changes. Biochemistry.
39:13005–13011. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kobayashi S, Sato M, Kasakoshi T, Tsutsui
T, Sugimoto M, Osaki M, Okada F, Igarashi K, Hiratake J, Homma T,
et al: Cystathionine is a novel substrate of cystine/glutamate
transporter: Implications for immune function implications for
immune function. J Biol Chem. 290:8778–8788. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu M, Du J, Chen S, Liu AD, Holmberg L,
Chen Y, Zhang C, Tang C and Jin H: L-Cystathionine inhibits the
mitochondria-mediated macrophage apoptosis induced by oxidized low
density lipoprotein. Int J Mol Sci. 15:23059–23073. 2014.
View Article : Google Scholar
|
|
26
|
Wang RH, Chu YH and Lin KT: The hidden
role of hydrogen sulfide metabolism in cancer. Int J Mol Sci.
22:65622021. View Article : Google Scholar
|
|
27
|
Wang M, Yan J, Cao X, Hua P and Li Z:
Hydrogen sulfide modulates epithelial-mesenchymal transition and
angiogenesis in non-small cell lung cancer via HIF-1α activation.
Biochem Pharmacol. 172:1137752020. View Article : Google Scholar
|
|
28
|
Payen VL, Porporato PE, Baselet B and
Sonveaux P: Metabolic changes associated with tumor metastasis,
part 1: Tumor pH, glycolysis and the pentose phosphate pathway.
Cell Mol Life Sci. 73:1333–1348. 2016. View Article : Google Scholar
|
|
29
|
Kim SH, Roszik J, Grimm EA and Ekmekcioglu
S: Impact of l-arginine metabolism on immune response and
anticancer immunotherapy. Front Oncol. 8:672018. View Article : Google Scholar
|
|
30
|
Simpson NE, Tryndyak VP, Beland FA and
Pogribny IP: An in vitro investigation of metabolically sensitive
biomarkers in breast cancer progression. Breast Cancer Res Treat.
133:959–968. 2012. View Article : Google Scholar
|
|
31
|
Albaugh VL, Pinzon-Guzman C and Barbul A:
Arginine-Dual roles as an onconutrient and immunonutrient. J Surg
Oncol. 115:273–280. 2017. View Article : Google Scholar
|
|
32
|
Carroll RJ, Ruppert D, Stefanski LA and
Crainiceanu CM: Measurement error in nonlinear models: A modern
perspective. Chapman and Hall/CRC; 2006
|
|
33
|
Wang LB, Shen JG, Zhang SZ, Ding KF and
Zheng S: Amino acid uptake in arterio-venous serum of normal and
cancerous colon tissues. World J Gastroenterol. 10:1297–1300. 2004.
View Article : Google Scholar
|
